Voxzogo 0,56 MG Polvo y Disolvente Para Solucion InyectableSpain · 0,56 mg · polvo y solución para solución inyectable · Biomarin International Limited

Voxzogo 1,2 MG Polvo y Disolvente Para Solucion InyectableSpain · 1,2 mg · polvo y solución para solución inyectable · Biomarin International Limited

VoxzogoEuropean Union · BioMarin International Limited

VoxzogoCroatia

VoxzogoItaly · Polvere e solvente per soluzione iniettabile · Biomarin International Limited

VoxzogoUnited States · 0.4MG/VIAL, 0.56MG/VIAL, 1.2MG/VIAL · powder · Biomarin Pharm

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Vosoritide
Dosage form: Poeder voor oplossing voor injectie
Route: Subcutaan gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 26 Aug 2021
Registration: EU/1/21/1577
Marketing authorisation holder: BioMarin International Limited
ATC code: M05BX07
Group: Musculo-skeletal system
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/005475
EU number: EU/1/21/1577

Netherlands

Voxzogo 1,4 mg, poeder en oplosmiddel voor oplossing voor injectieVosoritide · Poeder voor oplossing voor injectieNetherlands